Elena Puerta
Pamplona, NC, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 39 publications
Role of sirtuin 2 in the brain is cell-type and context-dependent: Implications for therapeutic targeting.
Journal: Neural regeneration research
Published: September 30, 2025
Microglial SIRT2 deficiency aggravates cognitive decline and amyloid pathology in Alzheimer's disease.
Journal: Brain, behavior, and immunity
Published: December 21, 2024
Astrocytic GLUT1 reduction paradoxically improves central and peripheral glucose homeostasis.
Journal: Science advances
Published: October 18, 2024
Zein nanoparticles extend lifespan in C. elegans and SAMP8 mice.
Journal: International journal of pharmaceutics
Published: July 30, 2024
Context-dependent role of sirtuin 2 in inflammation.
Journal: Neural regeneration research
Published: December 20, 2023
Age-Associated Changes of Sirtuin 2 Expression in CNS and the Periphery.
Journal: Biology
Published: October 28, 2023
Neuropathological stage-dependent proteome mapping of the olfactory tract in Alzheimer's disease: From early olfactory-related omics signatures to computational repurposing of drug candidates.
Journal: Brain pathology (Zurich, Switzerland)
Published: September 27, 2023
SIRT2 as a potential new therapeutic target for Alzheimer's disease.
Journal: Neural regeneration research
Published: July 25, 2023
SIRT2 Inhibition Rescues Neurodegenerative Pathology but Increases Systemic Inflammation in a Transgenic Mouse Model of Alzheimer's Disease.
Journal: Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology
Published: October 17, 2022
Hydrogels for brain repair: application to Parkinson's disease.
Journal: Expert opinion on drug delivery
Published: October 14, 2022
Fast antidepressant action of ketamine in mouse models requires normal VGLUT1 levels from prefrontal cortex neurons.
Journal: Progress in neuro-psychopharmacology & biological psychiatry
Published: March 12, 2022
Trimethylamine N-oxide (TMAO) drives insulin resistance and cognitive deficiencies in a senescence accelerated mouse model.
Journal: Mechanisms of ageing and development
Published: January 13, 2022
Last Updated: 09/26/2026